MIVACRON (nda020098)- (EQ 2MG BASE/ML (EQ 2MG BASE/ML),EQ 10MG BASE/5ML (EQ 2MG BASE/ML),EQ 20MG BASE/10ML (EQ 2MG BASE/ML))

Generic Name	MIVACURIUM CHLORIDE	Innovator	ABBVIE
Dosage	EQ 2MG BASE/ML (EQ 2MG BASE/ML),EQ 10MG BASE/5ML (EQ 2MG BASE/ML),EQ 20MG BASE/10ML (EQ 2MG BASE/ML)
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2006-Jan-22	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	MIVACRON is a short-acting neuromuscular blocking agent indicated for inpatients and outpatients, as an adjunct to general anesthesia, to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
1	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 2MG BASE/ML (EQ 2MG BASE/ML)	**	**	-	-	-
EQ 10MG BASE/5ML (EQ 2MG BASE/ML)	**	**	-	-	-
EQ 20MG BASE/10ML (EQ 2MG BASE/ML)	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of MIVACRON